Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
26 Apr 2024
Historique:
medline: 24 4 2024
pubmed: 24 4 2024
entrez: 24 4 2024
Statut: ppublish

Résumé

Critical aspects of physiology and cell function exhibit self-sustained ~24-hour variations termed circadian rhythms. In the liver, circadian rhythms play fundamental roles in maintaining organ homeostasis. Here, we established and characterized an in vitro liver experimental system in which primary human hepatocytes display self-sustained oscillations. By generating gene expression profiles of these hepatocytes over time, we demonstrated that their transcriptional state is dynamic across 24 hours and identified a set of cycling genes with functions related to inflammation, drug metabolism, and energy homeostasis. We designed and tested a treatment protocol to minimize atorvastatin- and acetaminophen-induced hepatotoxicity. Last, we documented circadian-dependent induction of pro-inflammatory cytokines when triggered by LPS, IFN-β, or

Identifiants

pubmed: 38657074
doi: 10.1126/sciadv.adm9281
doi:

Substances chimiques

Acetaminophen 362O9ITL9D
Atorvastatin A0JWA85V8F
Cytokines 0
Lipopolysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadm9281

Auteurs

Sandra March (S)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Niketa Nerurkar (N)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Anisha Jain (A)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Linda Andrus (L)

Laboratory of Virology and Infectious Disease, The Rockefeller University, NY, New York, USA.

Daniel Kim (D)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Charles A Whittaker (CA)

David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Edward K W Tan (EKW)

David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Sabine Thiberge (S)

Institut Pasteur, Université Paris Cité, Inserm U1201, CNRS EMR9195, Unité de Biologie des Interactions Hôte-Parasite, 75015 Paris, France.
Institut Pasteur, Université Paris Cité, Centre de Production et d'Infection des Anophèles, 75015 Paris, France.

Heather E Fleming (HE)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Liliana Mancio-Silva (L)

Institut Pasteur, Université Paris Cité, Inserm U1201, CNRS EMR9195, Unité de Biologie des Interactions Hôte-Parasite, 75015 Paris, France.

Charles M Rice (CM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, NY, New York, USA.

Sangeeta N Bhatia (SN)

Institute for Medical Engineering and Science, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.
Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Wyss Institute at Harvard University, 201 Brookline Ave, Boston, MA 02215, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH